“…Due to small number of patients in severe and critical categories, the lack of statistical significance for subgroup comparisons between RAC and DBC categories in the Acevedo-Piedra et al study 8 is expected. For example, using 40% prevalence of an outcome, a sample size of roughly 90 and 375 patients in each group is needed to detect a 20% or 10% reduction in outcome, respectively, with a power of 80% and an α of 0.05.…”